KNSA
Kiniksa Pharmaceuticals Ltd
75.80$
+0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | -15.9% | +577.9% | -20.9% | +37.3% | -33.4% | +97.5% | +14.5% | +10.3% | +31.5% | |
| – | -16.4% | +566.1% | -23.0% | +37.9% | -41.1% | +23.7% | +13.7% | +20.1% | +58.9% | |
| – | -18.6% | +574.6% | -84.7% | +143.0% | +7.4% | +0.2% | -12.0% | +70.1% | -9.8% | |
| – | -18.6% | +574.6% | -24.1% | +38.6% | -43.7% | +4.6% | +8.3% | +18.1% | +70.0% | |
| – | – | – | – | – | – | +409.8% | +4.7% | +96.2% | -62.6% | |
| – | – | – | – | – | – | +487.7% | +44.1% | -15.3% | +108.2% | |
| – | +48.8% | +4,984.8% | +31.0% | -51.3% | -30.0% | -41.5% | – | – | – | |
| – | – | – | – | – | – | -5.2% | -5.5% | -5.8% | -6.2% | |
| – | +66.9% | -68.9% | -31.8% | +28.9% | +27.3% | +33.0% | +37.7% | +62.5% | +37.9% | |
| – | +657.2% | +144.1% | -34.6% | +14.4% | +40.8% | +5.0% | +35.3% | +58.0% | +38.3% | |
| – | – | – | – | +24.2% | +60.5% | -2.4% | -31.7% | -11.5% | +49.9% | |
| – | +474.5% | +796.4% | -47.9% | -91.2% | +271.4% | +322.9% | +4.4% | -75.3% | -0.5% | |
| – | – | – | – | +38.4% | -40.7% | +114.1% | +10.8% | -0.1% | +29.5% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -9.0% | +82.9% | +14.4% | +10.9% | +2.7% | +2.1% | -0.7% | +10.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.